Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03087799 · ClinicalTrials.gov registry record · NA
Brief Behavioral Treatment for Sleep Problems in IBS Study
A NA study, sponsored by Beth Israel Deaconess Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 25
- Enrollment target
NCT03087799 is a NA study that has completed, run by Beth Israel Deaconess Medical Center. The registered enrollment target is 25 participants.
The verdict
NCT03087799, a NA study, has completed, sponsored by Beth Israel Deaconess Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 25 participants
- Enrollment target
Study Summary
Patients with Irritable Bowel Syndrome (IBS) often report more fatigue and sleep disturbances compared to their healthy counterparts and compared to patients with other GI disorders. This pilot study will evaluate the feasibility of a Brief Behavioral Treatment for Insomnia (BBT-I) in Irritable Bowel Syndrome. 40 participants will be recruited; 20 will receive 4 weeks of BBT and 20 will be assigned to a wait list control group (WLC). The primary aim of the current project is to assess feasibility of administering BBT-I to a sample of patients with IBS. Because behavioral sleep treatment has not yet been studied in IBS or any other GI population, this project will provide information about treatment adherence, recruitment, and effect sizes. Secondary aims include evaluating the impact of BBT-I on sleep quality and IBS symptom severity.
Interventions
- BEHAVIORAL Brief Behavioral Treatment for Sleep
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2017-03-03 |
| Est. Completion | 2019-08-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03087799
The ClinicalTrials.gov registry entry for NCT03087799 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 25 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Beth Israel Deaconess Medical Center, which has 488 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Brief Behavioral Treatment for Sleep is the first listed.
NCT03087799 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03087799 about?
NCT03087799 is a clinical study titled "Brief Behavioral Treatment for Sleep Problems in IBS Study". Patients with Irritable Bowel Syndrome (IBS) often report more fatigue and sleep disturbances compared to their healthy counterparts and compared to patients with other GI disorders. This pilot study will evaluate the feasibility of a Brief Behavioral Treatment for Insomnia (BBT-I) in Irritable Bowe...
What is the current status of trial NCT03087799?
This trial is currently completed. It is a NA study. The enrollment target is 25 participants. The study started on 2017-03-03. Estimated completion is 2019-08-08.
What interventions are being tested in trial NCT03087799?
The interventions under investigation include: Brief Behavioral Treatment for Sleep (BEHAVIORAL).
Who is sponsoring clinical trial NCT03087799?
This trial is sponsored by Beth Israel Deaconess Medical Center, which has 488 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.